Research

Our clinical research program focuses on new areas of treatment for which there has been little or no pharmaceutical investigation and where existing preparations have short-comings. Many conditions such as post natal depression, endometriosis, female androgen deficiency including female sexual dysfunction (FSD), male androgen deficiency and polycystic ovarian syndrome have underlying states of hormonal imbalance.


Studies Currently Recruiting


Effects of Testosterone and Exercise (TEX) on Fitness, Physical Activity and Vascular Health in Men. Perth, Australia

Learn more

A 2x2 factorial randomised controlled trial which will look at how testosterone and exercise could improve fitness and increase physical activity as well as improve the function of blood vessels.

Status: Currently recruiting

Lead Investigators: A/Prof Bu Yeap, University of Western Australia, Fiona Stanley Hospital, Western Australia.

Description: Testosterone combined with exercise training improves limb muscle strength and performance more than either alone. However, this combination has not been tested for its effects on fitness and blood vessels. This study will examine whether testosterone and exercise training improves the function of blood vessels more than either alone.

For further information click here.

Scrotal testosterone use in men. Sydney, Australia

Learn more

Pharacokinetics of Testosterone cream applied to scrotal skin.

Status: Fully recruited and completed. Publication of results pending

Lead Investigator: Professor David Handelsman, ANZAC Research Institute, Concord, Sydney

Description: The conventional use of testosterone cream, gel and solutions has been to the upper body in testosterone deficient men. Due to low absorption residual testosterone can be transferred to partners and children via contact. This study examines the absorption of testosterone cream when applied to scrotal skin which opens the potential to avoid passive transfer problems.

Testosterone Antidepressant Augmentation in Women : Boston USA

Learn more

Status: Fully recruited, publication pending

Principal Investigators: Assoc Prof Karen K Miller MD Harvard Medical School, Neuroendocrine Unit, Massachusetts General Hospital, Boston, USA.

This study is an 8-week randomized, placebo-controlled study of the effects of low-dose testosterone vs. placebo in 100 women with SSRI-resistant depression using AndroFeme® testosterone cream. This study is due to commence in July 2013. For further information contact KKMiller@partners.org.

Study Centres: Neuroendocrine Unit, Massachusetts General Hospital, Boston, USA and Butler Hospital, Rhode Island, USA.

Status: Recruiting

Testosterone and Alzheimer's Disease prevention. Perth, Australia

Learn more

A 52 week, double-blind, randomised, placebo-controlled trial to determine the efficacy of testosterone, with and without DHA supplementation in men with Subjective Memory Complaints as a strategy to prevent the development of Alzheimer’s Disease.

Principal Investigators: Professors Ralph Martins and Roger Clarnette, The McCusker Alzheimer Disease Research Foundation, Inc., Perth, Australia.

Status: Recruiting commenced January 2013

For more information contact The McCusker Alzheimer Disease Research Foundation on +61 8 93474200 or http://www.alzheimers.com.au.

Testosterone and IVF. Melbourne, Australia

Learn more

Use of transdermal testosterone cream in IVF pre-treatment and its effect on controlled ovarian stimulation and IVF outcome in poor responder IVF patients: A randomized placebo-controlled trial.

Lead Investigators:

Dr Shlomi Barak, Melbourne IVF, East Melbourne, Department of Obstetrics and Gynecology, University of Melbourne.

Status: Suspended

Latest News

not to be compounded STAMP

Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies

MEDIA RELEASE 3rd August 2017   A recent Federal Court...
Read more

FDA

FDA releases Industry Guidance for Low Sexual Interest, Desire and/or Arousal in Women

In late October 2016 the US FDA released draft guidance for...
Read more

female-orgasm

Flibanserin, the drug that gives women one extra sexually satisfying experience every two months

 The United States Food and Drug Administration (FDA)...
Read more